285 related articles for article (PubMed ID: 28215455)
1. Lung ablation: Best practice/results/response assessment/role alongside other ablative therapies.
de Baere T; Tselikas L; Gravel G; Deschamps F
Clin Radiol; 2017 Aug; 72(8):657-664. PubMed ID: 28215455
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous thermal ablation of primary lung cancer.
de Baere T; Tselikas L; Catena V; Buy X; Deschamps F; Palussière J
Diagn Interv Imaging; 2016 Oct; 97(10):1019-1024. PubMed ID: 27692673
[TBL] [Abstract][Full Text] [Related]
3. Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours.
Jahangeer S; Forde P; Soden D; Hinchion J
Cancer Treat Rev; 2013 Dec; 39(8):862-71. PubMed ID: 23601905
[TBL] [Abstract][Full Text] [Related]
4. Locally ablative therapies for primary and metastatic liver cancer.
Li D; Kang J; Madoff DC
Expert Rev Anticancer Ther; 2014 Aug; 14(8):931-45. PubMed ID: 24746315
[TBL] [Abstract][Full Text] [Related]
5. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
[TBL] [Abstract][Full Text] [Related]
6. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
[TBL] [Abstract][Full Text] [Related]
7. Novel methods for renal tissue ablation.
Olweny EO; Cadeddu JA
Curr Opin Urol; 2012 Sep; 22(5):379-84. PubMed ID: 22706069
[TBL] [Abstract][Full Text] [Related]
8. What's New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update.
Arellano RS
Curr Oncol Rep; 2020 Jul; 22(10):105. PubMed ID: 32725433
[TBL] [Abstract][Full Text] [Related]
9. Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis.
Cheng PL; Wu PH; Kao WY; Lai YT; Hsu JC; Chiou JF; Wu MH; Lee HL
Exp Hematol Oncol; 2023 Apr; 12(1):37. PubMed ID: 37046292
[TBL] [Abstract][Full Text] [Related]
10. [Thermal ablation of malignant lung tumours].
Schneider T
Zentralbl Chir; 2015 Feb; 140(1):104-8. PubMed ID: 25329865
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
13. Image-guided thermal ablation of lung malignancies.
Dupuy DE
Radiology; 2011 Sep; 260(3):633-55. PubMed ID: 21846760
[TBL] [Abstract][Full Text] [Related]
14. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer.
Kim SR; Han HJ; Park SJ; Min KH; Lee MH; Chung CR; Kim MH; Jin GY; Lee YC
Eur J Radiol; 2012 Feb; 81(2):395-9. PubMed ID: 21310562
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
16. The Role of Percutaneous Image-Guided Thermal Ablation for the Treatment of Pulmonary Malignancies.
Mouli SK; Kurilova I; Sofocleous CT; Lewandowski RJ
AJR Am J Roentgenol; 2017 Oct; 209(4):740-751. PubMed ID: 28657845
[TBL] [Abstract][Full Text] [Related]
17. Up-to-date evidence on image-guided thermal ablation for metastatic lung tumors: a review.
Matsui Y; Tomita K; Uka M; Umakoshi N; Kawabata T; Munetomo K; Nagata S; Iguchi T; Hiraki T
Jpn J Radiol; 2022 Oct; 40(10):1024-1034. PubMed ID: 35778630
[TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences?
Vroomen LGPH; Petre EN; Cornelis FH; Solomon SB; Srimathveeravalli G
Diagn Interv Imaging; 2017 Sep; 98(9):609-617. PubMed ID: 28869200
[TBL] [Abstract][Full Text] [Related]
19. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
Palma DA; Nguyen TK; Kwan K; Gaede S; Landis M; Malthaner R; Fortin D; Louie AV; Frechette E; Rodrigues GB; Yaremko B; Yu E; Dar AR; Lee TY; Gratton A; Warner A; Ward A; Inculet R
Radiat Oncol; 2017 Jan; 12(1):30. PubMed ID: 28129789
[TBL] [Abstract][Full Text] [Related]
20. Ablative therapies: Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient?
Seror O
Diagn Interv Imaging; 2015 Jun; 96(6):617-24. PubMed ID: 25981214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
